required for development of autoimmunity and joint inflammation in the K/BxN mouse model of autoimmune arthritis, and that SFB alone was sufficient to trigger this pathology. K/BxN mice, which were generated by crossing a T-cell receptor (TCR) transgenic line with the NOD strain, spontaneously develop a joint disease that has many features in common with rheumatoid arthritis in humans. In these mice, major histocompatibility complex class II-restricted presentation of a self-peptide derived from glucose-6-phosphate isomerase (GPI) to T cells displaying the transgenic TCR results in expansion of autoreactive T cells that provide help to GPI-specific B cells, resulting in high titers of anti-GPI autoantibodies. An interesting feature of this model is the generation of anti-GPI Th17 cells in the intestinal lamina propria that migrate to the spleen and promote the development of germinal centers and anti-GPI antibody-secreting cells. Joint inflammation in K/BxN mice results from a self-sustaining innate immune response initiated by GPI:anti-GPI immune complexes. Wu and colleagues found that K/BxN mice maintained under germ-free (GF) conditions had reduced anti-GPI autoantibody titers, Th17 cells, and joint inflammation as compared with genetically identical mice with a specific pathogen-free (SPF) gut microbiota. Transfer of GF K/ BxN mice to an SPF facility rapidly induced symptoms of arthritis, which could be prevented by treatment with IL-17-neutralizing antibodies. Significantly, monocolonization of GF K/BxN mice with SFB was sufficient to drive production of autoantibodies and pathogenic Th17 cells as well as to trigger arthritis. These results provide the first evidence that commensal bacteria can drive autoimmune arthritis by inducing a Th17 response in the intestine.
This important discovery offers new insights into the contribution of commensal gut bacteria and Th17 cells to the development of arthritis as a complication of intestinal inflammation. The potential relevance of this mechanism to human disease is supported by the recent report that frequencies of Th17
Out of joint: new insights into the role of commensal gut bacteria in autoimmune arthritis
It has long been appreciated that inflammation in the intestine can give rise to inflammation at extraintestinal sites, such as the skin, eyes, and joints. Transient spondyloarthritis occurs in 10-20% of patients with inflammatory bowel disease (IBD), usually during a flare of intestinal inflammation. 1 Current theories on the pathogenesis of IBD posit that inflammation results from an inappropriate immune response to gut bacteria in genetically predisposed individuals. Advances in metagenomic analysis of the gut microbiota have revealed that changes in the composition of the gut microbiota are commonly associated with IBD, although it remains unclear whether these changes are the cause or the result of intestinal inflammation. Alterations in the gut microbiota have also been reported in patients with early rheumatoid arthritis, 2 
